🇺🇸 FDA
Pipeline program

TACHOSIL GROUP

022018

Approved mab completed

Quick answer

TACHOSIL GROUP for Lymphocele is a Approved program (mab) at Takeda with 1 ClinicalTrials.gov record(s).

Program details

Company
Takeda
Indication
Lymphocele
Phase
Approved
Modality
mab
Status
completed

Clinical trials